Skip to main content

Jim Cramer on Stimulus, Interest Rates, J&J, Stock Market Monday

In Monday's stock market breakdown, Jim Cramer talks the Johnson & Johnson vaccine, Beyond Meat, stimulus, and fears circulating around the bond selloff.

What are you watching in the markets this week?

Sifting through the various headlines that trickled down both on early Monday morning and throughout the weekend, there are a handful of stocks and news items to pay attention to.

Joining TheStreet Live as the Dow surged upwards of 600 points, Jim Cramer said discipline is critical Monday. "The time to buy was Friday. You can't come in and say the time to buy was Monday," Cramer said. 

Jim Cramer talks the Johnson & Johnson  (JNJ) - Get Johnson & Johnson Report vaccine, Beyond Meat  (BYND) - Get Beyond Meat, Inc. Report, stimulus, and fears circulating around the bond selloff in the video below: 

First up: What's going on with bonds?

"Where are we in this bond-related selloff? Are we one-third through? Two-thirds? Or are we where we need to be to start buying?" Jim Cramer wrote over the weekend in a Real Money column.

"As I have said I have studied all the rate scares we have had in the last couple of decades and this one is pretty much following the form of those where the Fed feels pressure to raise rates off a very low base," he continued.

Now, let's talk about stimulus.

Scroll to Continue

TheStreet Recommends

Biden's pandemic relief bill was approved early Saturday by the U.S. House of Representatives, now goes to the Senate for approval.

However, it will not include the hike in the minimum wage that some Democrats had hoped for. But, it does still include the $1,400 stimulus checks that many Americans are waiting for.

Cramer advised to consider a negative market reaction to a Senate bill as an opportunity to buy the dip. 

Then Johnson & Johnson's vaccine received an emergency use authorization from the Food & Drug Administration.

On Saturday, Johnson & Johnson received the EUA.

And then, the one-shot COVID vaccine received an OK on Sunday afternoon from the Centers for Disease Control and Prevention.

The step is necessary to allow the company to begin distributing the vaccine in the U.S., making it the third such vaccine available for Americans.

Cramer said that if J&J can produce 100 million doses, "that will be the end of the pandemic." 

Curious about what Jim Cramer and his team at Action Alerts PLUS are watching in the markets? Watch Cramer's exclusive members-only Daily Rundown show on Action Alerts PLUS following TheStreet Live.

Daniel Kuhn contributed reporting to this article.